Kahira Pharmaceuticals & Chemical Industries Company (EGX: CPCI)

Market Cap	1.74B
Revenue (ttm)	1.36B
Net Income (ttm)	246.11M
Shares Out	14.93M
EPS (ttm)	16.48
PE Ratio	7.07
Forward PE	n/a
Dividend	7.00 (6.01%)
Ex-Dividend Date	Dec 24, 2024

Volume	4,459
Open	117.11
Previous Close	117.11
Day's Range	116.00 - 117.11
52-Week Range	52.13 - 119.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 28, 2024

About EGX: CPCI

Kahira Pharmaceuticals & Chemical Industries Company engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt. The company is involved in the provision of chemicals, extracts, veterinary medicines, and pesticides; and packaging and distribution activities. It also exports its products to Iraq, Yemen, Sudan, Somalia, Jordan, Libya, Senegal, Zimbabwe, South Sudan, Mali, and Kenya. Kahira Pharmaceuticals & Chemical Industries Company was founded in 1962 and is headquartered in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 1,883
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: CPCI

Financial Performance

In 2024, CPCI's revenue was 1.36 billion, an increase of 35.38% compared to the previous year's 1.01 billion. Earnings were 246.11 million, an increase of 153.48%.